Muscle density as a predictive marker for toxicities during ovarian cancer treat...
Dr Lucy Dumas - The Royal Marsden NHS Foundation Trust, London, UK
Muscle density as a predictive marker for toxicities during ovarian cancer treatment ( Dr Lucy Dumas - The Royal Marsden NHS Foundation Trust, London, UK )
23 Nov 2018
Using mobile technologies for cervical cancer data collection
Prof David Weller, University of Edinburgh
Using mobile technologies for cervical cancer data collection ( Prof David Weller, University of Edinburgh )
6 Nov 2018
Comment on 'Ovarian Cancer: An ESMO Guide for Patients'
Dr Nicoletta Colombo - Istituto Europeo di Oncologia, Milan, Italy
Comment on 'Ovarian Cancer: An ESMO Guide for Patients' ( Dr Nicoletta Colombo - Istituto Europeo di Oncologia, Milan, Italy )
1 Nov 2018
Combination strategies of immunotherapy in breast cancer
Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy
Combination strategies of immunotherapy in breast cancer ( Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2018
SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer
Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
26 Oct 2018
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic pr...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
The standard of care and progress so far with PARP inhibitors for ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The standard of care and progress so far with PARP inhibitors for ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
25 Oct 2018
Comment on the Every Woman Study
Clara MacKay - World Ovarian Cancer Coalition, Canada
Comment on the Every Woman Study ( Clara MacKay - World Ovarian Cancer Coalition, Canada )
24 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
The past, present and future of treating ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018
Comment on SOLO-1 for advanced ovarian cancer
Dr Jonathan Ledermann - University College London, London, UK
Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )
21 Oct 2018
Olaparib improves progression free survival up front in ovarian cancer
Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018